A randomized controlled double-blind study of rotigotine on neuropsychiatric symptoms in de novo PD
Abstract Management of apathy, depression and anxiety in Parkinson’s disease (PD) represents a challenge. Dopamine agonists have been suggested to be effective. This multicenter, randomized (1:1), double-blind study assessed the 6-month effect of rotigotine versus placebo on apathy, depression and a...
Guardado en:
Autores principales: | A. Castrioto, S. Thobois, M. Anheim, J. L. Quesada, E. Lhommée, H. Klinger, A. Bichon, E. Schmitt, F. Durif, J. P. Azulay, J. L. Houeto, N. Longato, C. Philipps, P. Pelissier, E. Broussolle, E. Moro, C. Tranchant, V. Fraix, P. Krack, for the Honeymoon study group |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/34b6579169b943c7944a08d2e7aba062 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Restless legs syndrome: differential diagnosis and management with rotigotine
por: Giovanni Merlino, et al.
Publicado: (2009) -
Rotigotine is safe and efficacious in Atypical Parkinsonism Syndromes induced by both a-synucleinopathy and tauopathy
por: Moretti DV, et al.
Publicado: (2014) -
Lower irritation microemulsion-based rotigotine gel: formulation optimization and in vitro and in vivo studies
por: Wang Z, et al.
Publicado: (2015) -
Neuropsychiatric symptoms and celiac disease
por: Urban-Kowalczyk M, et al.
Publicado: (2014) -
Optimising classification of Parkinson’s disease based on motor, olfactory, neuropsychiatric and sleep features
por: Jonathan P. Bestwick, et al.
Publicado: (2021)